Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: J Geriatr Oncol. 2022 Aug 24;13(8):1132–1140. doi: 10.1016/j.jgo.2022.08.005

Figure 1:

Figure 1:

Older Women with Non-metastatic Breast Cancer and Frequency-Matched Non-Cancer Controls Included in Analyses of Persistent Cognitive Decline.

The numbers of survivors and non-cancer controls are calculated among those who were eligible to participate in the study for at least two time points. Eligibility for multiple assessments in the study was the same as enrollment eligibility, and included having or developing a neurological disease (e.g., stroke, Parkinson’s disease). Characteristics of missing data and patterns of missing assessments by survivors and non-cancer control groups are summarized in Supplementary Section 1.